Cholesterol efflux pathways and other potential mechanisms involved in the athero‐protective effect of high density lipoproteins

Journal of Internal Medicine - Tập 263 Số 3 - Trang 256-273 - 2008
Alan R. Tall1
1Division of Molecular Medicine, Department of Medicine, Columbia University, NY, USA.

Tóm tắt

Abstract.Plasma high density lipoprotein (HDL) levels bear a strong independent inverse relationship with atherosclerotic cardiovascular disease. Although HDL has anti‐oxidant, anti‐inflammatory, vasodilating and anti‐thrombotic properties, the central anti‐atherogenic activity of HDL is likely to be its ability to remove cholesterol and oxysterols from macrophage foam cells, smooth muscle cells and endothelial cells in the arterial wall. To some extent, the pleotropic athero‐protective properties of HDL may be related to its ability to promote sterol and oxysterol efflux from arterial wall cells, as well as to detoxify oxidized phospholipids. In cholesterol‐loaded macrophages, activation of liver X receptors (LXRs) leads to increased expression of adenosine triphosphate (ATP) binding cassetter transporter (ABCA1), ATP binding cassetter transporter gene (ABCG1) and apoE and promotes cholesterol efflux. ABCA1 stimulates cholesterol efflux to lipid‐poor apolipoproteins, whilst ABCG1 promotes efflux of cholesterol and oxysterols to HDL. Despite some recent setbacks in the clinical arena, there is still intense interest in therapeutically targeting HDL and macrophage cholesterol efflux pathways, via treatments with niacin, cholesterol ester transfer protein inhibitors, LXR activators and infusions of apoA‐1, phospholipids and peptides.

Từ khóa


Tài liệu tham khảo

10.1016/B978-0-12-024911-4.50008-8

10.1161/CIRCULATIONAHA.104.475715

10.1074/jbc.M005438200

10.1038/11921

10.1038/11914

10.1038/11905

10.1172/JCI27352

10.1172/JCI200523915

10.1073/pnas.0403506101

10.1016/j.cmet.2005.01.002

10.1172/JCI27602

10.1126/science.271.5248.518

10.1002/hep.1840190507

10.1172/JCI29154

10.1126/science.204996

10.1172/JCI0216001

10.1172/JCI0216391

10.1210/me.2003-0061

10.1126/science.1099870

10.1172/JCI200420361

10.1172/JCI118082

10.1161/01.ATV.0000218998.75963.02

10.1161/01.ATV.0000200082.58536.e1

10.1161/ATVBAHA.106.138347

10.1161/01.CIR.0000093189.97429.9D

10.1194/jlr.M200475-JLR200

10.1021/bi035813p

10.1194/jlr.M300355-JLR200

10.1161/ATVBAHA.107.145789

10.1074/jbc.M505566200

10.1073/pnas.96.20.11358

10.1074/jbc.M314160200

10.1074/jbc.M103264200

10.1074/jbc.M107938200

10.1172/JCI200316808

10.1074/jbc.M202996200

10.1161/01.ATV.0000144811.94581.52

10.1073/pnas.0237205100

10.1097/00041433-199610000-00012

10.1038/sj.cdd.4401444

10.1161/01.ATV.0000184783.04864.9f

10.1074/jbc.M605603200

10.1073/pnas.0704602104

10.1161/01.CIR.0000146333.20727.2B

10.1161/01.CIR.97.12.1129

10.1073/pnas.0510345103

10.1189/jlb.0307192

10.1084/jem.20031763

10.1161/01.CIR.100.6.594

10.1161/01.ATV.0000161928.16334.dd

10.1161/CIRCULATIONAHA.105.560177

10.1161/01.CIR.0000086981.09834.E0

10.1172/JCI32057

10.1161/01.ATV.13.12.1814

10.1016/S0022-2275(20)33893-1

10.1161/01.ATV.0000092328.66882.F5

10.1161/hh0302.104462

10.1074/jbc.274.4.2366

10.1161/01.ATV.20.4.1068

10.1194/jlr.M600136-JLR200

10.1016/S0140-6736(02)07277-X

10.1161/01.ATV.0000014804.35824.DA

10.1073/pnas.092327399

10.1073/pnas.112059299

10.1073/pnas.182199799

10.1161/01.ATV.0000178996.91277.fb

10.1101/gad.844900

10.1172/JCI31909

10.1161/01.ATV.0000237629.29842.4c

10.1161/01.ATV.0000240051.22944.dc

10.1161/01.ATV.0000242275.92915.43

10.1016/j.immuni.2004.09.003

10.1038/28406

10.1161/01.ATV.15.11.1987

10.1074/jbc.274.46.33143

10.1161/01.CIR.0000159351.95399.50

10.1172/JCI6577

10.1161/CIRCULATIONAHA.105.607135

10.1073/pnas.0403259101

10.1073/pnas.0511043103

10.1161/01.RES.0000225982.01988.93

10.1074/jbc.275.15.11278

10.1038/89986

10.1161/01.CIR.89.6.2525

10.1161/01.CIR.0000070934.69310.1A

10.1172/JCI23858

10.1172/JCI16777

10.1172/JCI200418004

10.1161/01.CIR.0000147827.43912.AE

10.1161/CIRCULATIONAHA.106.649954

10.1016/S0021-9258(18)34477-6

Pomerantz KB, 1985, Enrichment of endothelial cell arachidonate by lipid transfer from high density lipoproteins: relationship to prostaglandin I2 synthesis, J Lipid Res, 26, 1269, 10.1016/S0022-2275(20)34274-7

10.1161/01.ATV.17.12.3481

10.1161/01.RES.0000199272.59432.5b

10.1001/jama.290.17.2292

10.1001/jama.290.17.2322

10.1016/j.atherosclerosis.2005.03.008

10.1161/ATVBAHA.107.148403

10.1001/jama.297.15.jpc70004

10.1161/ATVBAHA.107.148817

10.1001/jama.285.12.1585

10.1016/S0140-6736(05)67667-2

10.1016/j.amjcard.2007.03.024

10.1038/342448a0

10.1056/NEJM199011013231803

10.1056/NEJMe078029

10.1161/01.ATV.0000256728.60226.77

10.1056/NEJMoa070635

10.1016/S0140-6736(07)61088-5

10.1056/NEJMoa071359

10.1172/JCI108833

Shepherd J, 1987, Pharmacological modification of lipoprotein metabolism, Biochem Soc Trans, 15, 199, 10.1042/bst0150199

10.1038/nm824

10.1016/j.bbrc.2007.02.079

10.1172/JCI23626

10.1073/pnas.0601574103

10.1067/mhj.2002.123145

10.1161/01.ATV.0000183727.90611.4f

Thông tin
Thông tin xuất bản

Journal of Internal Medicine

Tập 263 Số 3

256-273

Thông tin tác giả